首页 / 院系成果 / 成果详情页

Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1 beta-mediated inhibition of glucose stimulated insulin secretion by mouse insulinoma beta cells  期刊论文  

  • 编号:
    b8d8cde9-fab1-4d54-8786-f0597670e418
  • 作者:
    Niu, Ben#[1,2]Li, Chao[3];Su, Heng*[2]Li, Qingzhu[2];He, Qiu[2];Liu, Lijuan[4];Xue, Yuanming[2];Shen, Tao[5];Xia, Xueshan*[6]
  • 语种:
    英文
  • 期刊:
    EXPERIMENTAL AND THERAPEUTIC MEDICINE ISSN:1792-0981 2017 年 14 卷 3 期 (2671 - 2676) ; SEP
  • 收录:
  • 关键词:
  • 摘要:

    The aim of the present study was to investigate the protective effect of the glucagon-Like peptide-1 receptor agonist exendin-4 on the interleukin (IL)-1 beta-induced impairment of glucose-stimulated insulin secretion (GSIS) in (beta-TC-6 cells. beta-TC-6 cells were pretreated with various concentrations of IL-beta (0.15, 1.5 or 15 ng/ml) and exendin-4 (0.1 or 1 mM). Exendin-4 was administered to beta-TC-6 cells prior to, during and following pretreatment. Cells were stimulated with various concentrations of glucose (0, 1.38, 5.5 and 11.1 mM), and insulin was measured via radioimmunoassay of the supernatant; furthermore, western blot analysis was used to detect phosphorylated extracellular receptor kinase (ERK)1/2. The insulin levels (151.08 +/- 14.34 mu IU/ml) and ERK1/2 phosphorylation in beta-TC-6 cells peaked in response to 1.38 mM glucose stimulation compared with 0, 5.5 and 11.1 mM glucose stimulation. IL-113 inhibited GSIS in a dose-dependent manner: Insulin levels were 83.76 +/- 1.16 mu IU/ml when 0.15 ng/ml IL-1 beta was added under GSIS, 59.46 +/- 3.20 mu IU/ml when 1.5 ng/ml IL-1 beta was added under GSIS, and 56.98 +/- 1.19 mu IU/ml when 15 ng/ml IL-1 beta was added under GSIS. Exendin-4 exerted a protective effect against IL-1 beta-induced GSIS inhibition in a dose-dependent manner. The greatest protective effect was observed when exendin-4 was added prior to IL-1 beta pretreatment, which was statistically significant (P<0.05). These findings suggested that exendin-4 was able to reverse the IL-1 beta-induced inhibition of ERK1/2 phosphorylation and serves a protective role by impairing GSIS induced by IL-beta in beta-TC-6 cells. This mechanism may be associated with the recovery of ERK1/2 activation.

  • 推荐引用方式
    GB/T 7714:
    Niu Ben,Li Chao,Su Heng, et al. Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1 beta-mediated inhibition of glucose stimulated insulin secretion by mouse insulinoma beta cells [J].EXPERIMENTAL AND THERAPEUTIC MEDICINE,2017,14(3):2671-2676.
  • APA:
    Niu Ben,Li Chao,Su Heng,Li Qingzhu,&Xia Xueshan.(2017).Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1 beta-mediated inhibition of glucose stimulated insulin secretion by mouse insulinoma beta cells .EXPERIMENTAL AND THERAPEUTIC MEDICINE,14(3):2671-2676.
  • MLA:
    Niu Ben, et al. "Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1 beta-mediated inhibition of glucose stimulated insulin secretion by mouse insulinoma beta cells" .EXPERIMENTAL AND THERAPEUTIC MEDICINE 14,3(2017):2671-2676.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:77 下载次数:0
浏览次数:77
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部